Background. The optimal timing of initiating renal replacement therapy in patients with chronic renal failure remains uncertain. The primary objective of our study is to determine whether delaying dialysis initiation as a result of patients' choice may have any impact on survival in subjects with end-stage renal disease. Methods. We prospectively studied the clinical outcome during the first year of all consecutive patients (n ¼ 233) deemed suitable for peritoneal dialysis (PD) after pre-dialysis counselling over a 2-year period from 2002 to 2004. All patients who were offered dialysis were included in the analysis from the day of initial counselling regardless of whether or not they were eventually established on PD.
Introduction
The optimal time to commence dialysis in patients with chronic renal failure remains unclear. A number of studies published in the last decade [1] [2] [3] [4] supported the notion that starting dialysis at a relatively high level of glomerular filtration rate (GFR) may be beneficial in terms of morbidity, mortality, employment opportunity and quality of life. These studies, however, were confounded by various factors such as referral-time and lead-time bias, comorbidity, compliance, age and non-uniform dialysis regimens and techniques. Indeed, after eliminating lead-time bias, two recent reports revoked the potential benefits of early initiation of dialysis [5, 6] . However, one of these studies comprising over 250 participants conducted in the Netherlands [6] has been criticized for not applying the appropriate standard of correction for such bias [7] . Therefore, the issue of how to correct for lead-time bias and when best to start dialysis has remained a matter of controversy and heated debate [8] . Nevertheless, the contemporary recommended threshold GFRs for initiating dialysis range from 10-12.5 ml/min [9, 10] .
Despite adequate pre-dialysis preparation and counselling, many patients either remain in denial of their renal disease or the need for dialysis, or simply cannot come to terms with the reality of having to initiate dialysis. And it is not unusual for the practicing nephrologist to encounter patients who refuse the commencement of dialysis until they develop significant symptoms of uraemia, fluid overload or malnutrition, when they become 'forced' to accept and commence dialysis. Delaying initiation literally to the 'last minute' may have profound implications on patients' psychological well-being (extra time free of dialysis), overall healthcare economics and dialysis outcomes. While it may not be ethically feasible to randomize patients to delay dialysis till the onset of uraemic symptoms, the present study aims to prospectively compare the clinical course and outcome of patients who complied with elective commencement of dialysis and those who did not.
Materials and methods

Patients
We prospectively followed the clinical outcome of all incident patients entering our peritoneal dialysis (PD) programme over a 2-year period from 2002 to2004. Continuous ambulatory peritoneal dialysis is the first line and most predominant form of dialytic therapy in Hong Kong [11] . All patients with chronic renal failure and their close relatives were invited to attend a multidisciplinary predialysis counselling seminar jointly conducted by the renal physician, nurse specialist, dietician, rehabilitation physiotherapist, community rehabilitation nurse and medical social worker, when their reciprocal of serum creatinine vs time plot predicted that end-stage renal failure (GFR below 10 ml/min/1.73 m 2 ) was impending within the next 6-12 months. Patients were then counselled individually by the nurse specialist in PD. Patients who accepted dialysis were scheduled for Tenckhoff catheter insertion followed immediately by initiation of intermittent PD (twice weekly, in-hospital, cycler-driven exchanges of 24-30 l of PD fluid lasting typically 3-5 weeks) until PD training. Patients who were commenced on PD in this manner were regarded as 'elective starters'. Patients who were deemed suitable for PD but declined initiation despite adequate counselling were deemed 'initial refusers', and continued to be monitored at the low clearance clinic. The clinical outcome of elective starters and initial refusers were tracked from the moment dialysis was offered to them and all subsequent follow-up and comparisons between elective starters and initial refusers were based on this starting point. Outcome measures included all subjects who were offered dialysis, regardless of whether they were eventually established on dialysis or not, or received renal transplantation. Those initial refusers who subsequently developed uraemic symptoms or emergencies that prompted them to agree to be initiated on dialysis were considered 'late starters'. Patients with inadequate documentation of GFR before the start of dialysis, history of malignancy and previous renal transplantation were excluded. The study protocol was reviewed and approved by the Clinical Research Ethics Committee and Institutional Review Board of the Hong Kong Hospital Authority.
GFR measurement before dialysis
Patients with serum creatinine over 400 mmol/l were regarded as having low clearance, and were followed at 4-6 weekly intervals. At each clinic visit, GFR was estimated by taking the average of urea and creatinine clearances calculated from 24-h urine samples and simultaneous serum urea and creatinine levels, and corrected for body surface area.
Dialysis protocol and follow-up
Upon the initiation of dialysis, the particular PD system employed was solely the choice of the patient after they had visited the PD centre and received detailed information from the nurse specialist on the various brands, modes and connectologies of PD. In Hong Kong, all dialysis solutions are provided free by its statutory healthcare regulatory organization, the Hong Kong Hospital Authority. Patients will only need to bear the cost of consumable items, such as connection tubings, and antiseptic solutions.
Patients performed 3-4 daily exchanges of 2 l PD fluid using either UltraBag (Baxter Healthcare, Guangzhou, People's Republic of China) or AndyDisk (Fresenius Medical Care, Bad Homburg, Germany) system. Adequacy of dialysis was assessed at the steady state when patients were established on PD for $2 months. Peritoneal membrane transport properties were assessed at the same setting using standard peritoneal equilibration test [12] . Dialysis regimens were adjusted to achieve euvolaemia and a weekly peritoneal Kt/V of at least 1.7, as this level of adequacy is found to be a minimum target for incident Chinese subjects [13] .
All pertinent clinical data during PD including peritonitis and other infective episodes, exit site-related problems, ultrafiltration status, dialysis adequacy, hospitalization record, blood transfusion, erythropoietin requirement and other drug prescriptions, and major adverse events were carefully documented.
Outcome measurements
The primary clinical outcomes evaluated were all-cause mortality and cardiovascular mortality. Cardiovascular mortality included death associated with a definite myocardial ischaemic event, heart failure, cerebrovascular accident and arrhythmia. Secondary outcomes included hospitalization and peritonitis rates, transfusion requirement, haemoglobin levels, nutritional status and transfer to another mode of renal replacement therapy. Initial refusers who underwent pre-emptive kidney transplantation and those who remained free of dialysis were not censored to avoid selection bias of patients with the worst prognosis in this group. If a patient died within 3 months of transfer to haemodialysis (HD), the death was not censored because such mortality was considered to reflect the health status during PD. During the period of follow-up, all deaths were accurately recorded with the exact cause of death provided by the attending physician. In the case of death out of hospital, family members were interviewed by telephone to ascertain the cause of death.
Statistical analyses
Data were expressed as means AE SD unless otherwise specified. Statistical analyses were performed using SPSS for Windows software version 12.0 (Statistical Package for the Social Sciences Inc., Chicago, IL, USA). Comparisons between groups were performed by 2 test for categorical data, and Mann-Whitney U-test for continuous data. Cumulative one-year survival was calculated using the Kaplan-Meier method, and comparisons between groups were made with the log-rank test. Unadjusted and adjusted hazard ratios were calculated for elective starters and initial refusers by Cox's proportional-hazards regression analysis. We adjusted all ratios for age, sex, and GFR at the point of inclusion and primary diabetic kidney disease, since the latter is known to adversely affect overall outcome. P < 0.05 was considered significant. All probabilities were two-tailed.
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Results A total of 233 subjects were recruited. There were 151 elective starters, and 82 initial refusers. The recruitment status is shown in Figure 1 . Baseline demographic characteristics and clinical parameters are shown in Table 1 and two (2.4%) were lost to follow-up. Sixty-eight subjects continued to be followed at the low clearance clinic. After a mean of 3.3 AE 0.7 months, 45 (55%) of them developed symptomatic uraemia or a uraemic emergency that prompted them or their family to retract their original refusal decision, and they were treated with emergency HD via a temporary dual lumen venous catheter. The reasons for initiating acute HD were as follows: shortness of breath in 16 (35.6%), significant nausea and vomiting in 10 (22.2%), significant oedematous state in 10 (22.2%), refractory hyperkalaemia with or without cardiac dysrhythmias in eight (17.8%), bleeding diathesis (epistaxis) in one (2.2%). Of these 45 subjects, 39 underwent Tenckhoff catheter insertion after a median of 2 weeks when their acute condition became stabilized with temporary intermittent HD, and were subsequently established on CAPD (late starters). Three patients died shortly after the commencement of temporary intermittent HD support (one from acute myocardial infarction, one from heart failure and one from sepsis). Another three patients revoked their decision to accept longterm dialysis once again after emergency HD, and subsequently died upon withdrawal of dialysis. The remaining 23 initial refusers continued to be followed at the low clearance clinic, and three patients died within the first year. Patients were progressively enrolled into the study. The 1-year all-cause mortality was 6.6% among the elective starters, and 18.3% among the initial refusers (P ¼ 0.004; Figure 2 ). The corresponding values for 1-year cardiovascular mortality were 2.6 and 9.8% (P ¼ 0.014), respectively ( Figure 3) . The causes of death in each group were shown in Table 2 . The results of the Cox proportional-hazard model are shown in Table 3 . The unadjusted hazard ratio for overall survival among initial refusers compared with elective starters was 3.12 (95% CI 1.34-9.88, P ¼ 0.011). After adjustment for age, sex, GFR and diabetic status, the hazard ratio was 3.01 (95% CI 1.32-9.40. P ¼ 0.01).
Among elective starters and those initial refusers who were eventually established on maintenance dialysis (late starters), the steady-state peritoneal Kt/V for urea, peritoneal creatinine clearance and D/P for creatinine at 4 h were not different (Table 4) . Renal Kt/V for urea and residual creatinine clearance were expectedly lower among late starters. Among secondary outcome measures, late starters had a higher number of hospital admissions (3.14 AE 1.17 vs 2.13 AE 1.13 episodes/person-year, P ¼ 0.05), blood transfusion need (0.8 AE 0.35 vs 0.38 AE 0.07 episodes/ person-year, P ¼ 0.033), peritonitis rates (18 vs 42 patient-months/episode, P ¼ 0.003) and lower serum albumin (30.9 AE 4.1 vs 34.0 AE 3.5 g/l, P ¼ 0.01) and normalized protein catabolic rate (0.96 AE 0.37 vs 1.28 AE 0.30, P ¼ 0.047) during the first year of dialysis. There were no significant differences in overall erythropoietin requirement, exit site problems and probability of receiving renal transplantation.
Probability of cardiovascular event-free survival
Weeks of follow-up Fig. 3 . Kaplan-Meier analysis of cardiovascular event-free 1-year survival. Follow-up was tracked from the moment dialysis was offered to both groups of subjects. All counselled patients were included regardless of whether they were eventually established on dialysis or not, or received renal transplantation by 52 weeks of the initial counselling.
Probability of survival
Weeks of follow-up Fig. 2 . Kaplan-Meier analysis of overall 1-year survival. Follow-up was tracked from the moment dialysis was offered to both groups of subjects. All counselled patients were included regardless of whether they were eventually established on dialysis or not, or received renal transplantation by 52 weeks of the initial counselling. a Expressed as number (%).
Late initiation of PD worsens clinical outcome 1929
Discussion
A number of investigators have tried to explore the optimal timing of initiating dialysis by comparing clinical outcomes in patients with chronic renal failure starting dialysis at various pre-defined levels of GFR, and produced mixed and inconclusive results [2, 6, 14, 15] . However, in real-life practice many patients approaching end-stage renal disease (ESRD) do not comply with these pre-defined GFR levels at which to initiate dialysis, but choose to delay the onset of dialysis for as long as they can in order to enjoy extra time free of dialysis. As a result, many patients are started on dialysis at GFR levels well below the recommended thresholds. To date, there has been no published trial that addresses the outcome of patients who are started on dialysis as late as the onset of symptomatic uraemia. Such trials are understandably difficult to conduct because of ethical considerations, and the possibility of life-threatening or irreversible complications when dialysis is started literally at the very 'last moment'. The immediate advantages of delaying the initiation of dialysis include extra time without dialysis on the patient's part, and alleviation on the part of any healthcare system of the everescalating burden of renal replacement therapy, the aggregate cost of which has been projected to exceed US$ 1 trillion during the next decade [16] . However, Residual creatinine clearance was calculated by averaging urea and creatinine clearance rates estimated from 24-h urine collections when urine output exceeded 100 ml/day. According to the method of peritoneal equilibration test (PET) and classification of transport status by Twardowski [12] .
e Derived from the Randerson formula [24] . it is not known whether such an approach may cast an adverse effect on clinical outcome. In this prospective cohort study, we addressed this issue by comparing the outcome of patients who complied with starting dialysis at a pre-defined standard, and those who refused to undergo initiation of dialysis despite adequate counselling on the tangible risks of delaying renal replacement therapy. To avoid lead-time bias, we tracked the outcomes of all subjects from the point dialysis was recommended to them. The initial refusers probably represented a heterogeneous group of patients comprising at least three categories: (i) patients with prolonged denial of disease who would finally agree to commence dialysis upon the development of significant uraemic symptoms and the sensation of impending demise; (ii) patients who were determined from the outset not to undergo renal replacement therapy no matter what; (iii) patients who rejected the idea of dialysis firmly but actively sought alternative forms of renal replacement therapy such as pre-emptive transplantation. The final decision is possibly influenced by multiple factors, including individual preference and disease perception, socioeconomic status, religious belief and educational and cultural background. And the issue is further complicated by an unpredictable swing from one decision to another. In this cohort, three initial refusers who had agreed to receive dialysis upon the development of uraemic symptoms finally decided to withdraw from treatment. From our data, it is apparent that although initial refusers as a group gained extra time off dialysis, this must be offset by significant survival disadvantages in the ensuing 12 months, taking into account all the counselled subjects regardless of whether they were eventually established on dialysis or not, or received pre-emptive renal transplantation. Our results showed that compared with elective starters, initial refusers had significantly worse overall as well as cardiovascular event-free survival at 1 year. Such survival disadvantage remained evident after adjusting for age, gender, GFR level upon recruitment and diabetic status, which is known to affect overall prognosis in the dialysis population. At the same time, one must not neglect the potential risk of over-fitting in our multivariate model, as the total number of cardiovascular deaths during this 1-year study was low.
Although approximately half of the initial refusers were eventually started on maintenance dialysis with comparable peritoneal adequacy indices, these late starters still fared worse than the elective starters. An important determinant was the lower residual renal function among the late starters. Indeed, a number of studies, including the recent reanalysis of the CANUSA study, have demonstrated that residual renal function, rather than peritoneal clearance, predicts survival [17] [18] [19] . A commonly held belief of the advantage conferred by residual renal function is that endogenous urine production helps maintain euvolaemia, thereby alleviating the burden of fluid overload on the cardiovascular system. More recently, we showed that residual renal function negatively correlates with all-cause and cardiovascular mortality in PD [20] . Another important determinant of volume status is peritoneal membrane transport characteristic, which is inversely related to patient and technique survival [21] . Here, there was no difference in dialysate to plasma creatinine ratio at 4 h between the two groups. Nevertheless, a recent study found that the predictive value of peritoneal membrane permeability needs to be interpreted in conjunction with residual renal function [22] .
Greater residual renal function might be associated with better preserved renal endocrine function. This may be reflected by the greater transfusion requirement among the late starters, although there was no difference in erythropoietin usage, which may be confounded by the fact that its usage in Hong Kong is only partially reimbursed and many patients may not opt to receive erythropoietin due to financial constraint. Finally, greater small-solute clearances are associated with better dietary intake and better nutrition. We previously demonstrated significant and independent effect of residual renal function, but not PD solute clearance, on actual dietary protein, calorie and other nutrient intake in patients on CAPD [23] . In the present cohort, elective starters had higher serum albumin levels and marginally higher normalized protein catabolic rate. The latter may not be a satisfactory nutritional marker because of its mathematical coupling with Kt/V and creatinine clearance as they were all computed from the same 24-h urine and dialysate collection. In any case, better nutritional status among elective starters may be supported by their lower peritonitis and hospitalization rates.
In conclusion, patients who refused timely start of dialysis have worse overall outcome at 1 year after dialysis was offered to them, compared with elective starters. This is probably mediated through multiple mechanisms including accelerated atherosclerosis and heightened systemic inflammation, fluid overload, anaemia, anorexia, poorer nutritional status, increased vulnerability to infection and reduced compliance with therapy. Although the optimal timing of starting dialysis remains to be defined, initiating at the inception of uraemic symptoms is probably too late.
